Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeability.
Joossens
S
S
Suenaert
P
P
Noman
M
M
Vermeire
S
S
Rutgeerts
P
P
D000328:Adult; D000908:Antibodies, Fungal / Q000276:immunology*; D000917:Antibody Formation; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology*; D005260:Female; D006801:Humans; D007422:Intestines / Q000276:immunology / Q000382:microbiology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010539:Permeability; D019936:Probiotics / Q000627:therapeutic use*; D012440:Saccharomyces; D012441:Saccharomyces cerevisiae / Q000276:immunology*; D016896:Treatment Outcome
D000908:Antibodies, Fungal